Tellgen Corp

300642 · SHE · Healthcare / Medical Devices

15.41CNY-0.81 (-4.99%)

Price History

Full chart

Market Stats

Previous Close16.22

Open16.16

Day Range15.32 – 16.38

52-Week Range11.01 – 29.72

Volume9.00M

Market Cap3.38B

P/E (TTM)260.50

Forward P/E0.00

EPS0.08

Dividend Yield0.72%

Beta0.28

50-Day Avg15.71

200-Day Avg16.30

About

Tellgen Corporation research, development, production, and sales of in-vitro diagnostic products in China and internationally. The company offers fully automatic flow fluorescence analyzer and CLIA analyzer; molecular test such as HPV test, lung cancer, colon cancer, personalized medicine, and infertility; and automatic integrated gene detection systems. It also provides tumor detection products; HPV nucleic acid testing products; methylation mutation detection products; detection products for invasive fungal diseases. The company was founded in 2003 and is based in Shanghai, China.

Company Details

SectorHealthcare
IndustryMedical Devices
CEOMr. Jian Er Yao
Employees683
HeadquartersNo. 412 Huiqing Road, Shanghai, China, 201201, China
Websitehttps://www.tellgen.com

Leadership

Mr. Jian Er YaoNon-Independent Chairman of Board & GM · b. 1970
Mr. Songtao LiFinancial Manager & Accounting Supervisor · b. 1976
Mr. En Huan YangDeputy GM & Non-Independent Director · b. 1982
Mr. Xiaoqing WangDeputy GM, Secretary of Board of Directors, Director of GM's Office & Non-Independent Director · b. 1979
Mr. Ye ShengDirector of R&D and Deputy GM · b. 1981

Financials

Income Statement

Currency: CNY	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	48.71M	76.83M	118.20M	169.38M	231.22M	302.89M	364.85M	441.45M	489.58M	654.59M	715.97M	542.81M	436.78M	363.83M
Growth (%)	-	+57.72%	+53.85%	+43.30%	+36.51%	+31.00%	+20.46%	+21.00%	+10.90%	+33.70%	+9.38%	-24.19%	-19.53%	-16.70%
Cost of Revenue	10.31M	15.27M	22.35M	31.95M	45.67M	59.73M	78.94M	95.56M	167.11M	220.40M	309.00M	188.42M	156.72M	110.76M
Gross Profit	38.41M	61.56M	95.85M	137.43M	185.55M	243.16M	285.91M	345.89M	322.47M	434.19M	406.97M	354.39M	280.06M	253.07M
Gross Margin	78.84%	80.12%	81.09%	81.14%	80.25%	80.28%	78.36%	78.35%	65.87%	66.33%	56.84%	65.29%	64.12%	69.56%
Operating Expense	24.93M	37.53M	55.23M	64.99M	79.65M	95.95M	120.48M	164.08M	190.22M	253.65M	275.54M	266.03M	241.43M	214.57M
Operating Income	13.48M	24.03M	40.63M	72.44M	105.90M	147.21M	165.42M	181.81M	132.25M	180.54M	131.43M	88.36M	38.63M	38.50M
Operating Margin	27.67%	31.27%	34.37%	42.77%	45.80%	48.60%	45.34%	41.19%	27.01%	27.58%	18.36%	16.28%	8.84%	10.58%
EBITDA	16.58M	31.60M	52.59M	90.24M	131.23M	171.43M	197.50M	224.25M	186.03M	246.35M	206.92M	161.50M	98.30M	59.54M
EBITDA Margin	34.04%	41.13%	44.49%	53.28%	56.75%	56.60%	54.13%	50.80%	38.00%	37.64%	28.90%	29.75%	22.51%	16.36%
Net Income	13.62M	22.58M	36.00M	65.78M	97.77M	126.81M	141.69M	157.02M	120.55M	161.08M	124.76M	89.40M	34.53M	3.59M
Net Income Margin	27.96%	29.39%	30.46%	38.83%	42.28%	41.87%	38.84%	35.57%	24.62%	24.61%	17.42%	16.47%	7.91%	0.99%
R&D	-	9.95M	18.63M	18.13M	21.77M	29.65M	40.00M	51.99M	61.47M	72.71M	79.33M	77.72M	65.72M	58.46M
R&D as % of Total Revenue	-	12.95%	15.76%	10.71%	9.42%	9.79%	10.96%	11.78%	12.56%	11.11%	11.08%	14.32%	15.05%	16.07%
Interest Expense	-	-	995.13K	848.13K	630.94K	397.69K	51.56K	117.06K	256.52K	1.28M	859.97K	854.04K	615.28K	2.56M
Interest Expense % of Total Revenue	-	-	0.84%	0.50%	0.27%	0.13%	0.01%	0.03%	0.05%	0.20%	0.12%	0.16%	0.14%	0.70%

Balance Sheet

Currency: CNY	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	81.34M	127.92M	161.77M	230.80M	340.53M	935.16M	1.10B	1.25B	1.37B	1.50B	1.66B	1.68B	1.75B	2.06B
Total Liabilities	8.87M	32.88M	30.72M	38.47M	51.88M	39.31M	78.68M	77.84M	105.19M	102.59M	184.07M	144.05M	230.94M	576.38M
Total Equity	72.47M	95.04M	131.05M	192.33M	288.65M	895.86M	1.02B	1.17B	1.27B	1.39B	1.47B	1.53B	1.51B	1.43B
Cash	40.45M	36.85M	53.27M	76.62M	116.18M	608.02M	504.87M	342.19M	313.68M	186.21M	243.49M	389.31M	308.74M	386.08M
Total Debt	-	14.33M	12.60M	11.20M	15.37M	-	26.48M	17.52M	16.45M	16.90M	21.93M	6.02M	97.15M	-
Net Debt	-40.45M	-22.52M	-40.67M	-65.42M	-100.81M	-608.02M	-478.39M	-324.67M	-291.89M	-169.31M	-221.56M	-380.40M	-211.59M	-

Cash Flow

Currency: CNY	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	6.85M	26.33M	40.81M	64.67M	98.42M	106.00M	161.32M	174.84M	96.83M	82.61M	164.72M	126.40M	164.62M	143.23M
Investing Cash Flow	-11.12M	-43.96M	-21.69M	-36.48M	-64.22M	-79.49M	-266.95M	-309.42M	-85.18M	-168.56M	-67.50M	42.63M	-286.86M	-
Financing Cash Flow	20.00M	14.04M	-2.70M	-6.72M	6.49M	465.34M	2.48M	-28.11M	-40.16M	-39.94M	-46.70M	-30.98M	39.03M	-
Capital Expenditure	11.80M	44.35M	22.14M	38.30M	64.92M	75.42M	144.50M	100.19M	79.48M	113.77M	66.90M	101.26M	86.49M	67.34M
Free Cash Flow	-4.95M	-18.02M	18.67M	26.36M	33.50M	30.58M	16.81M	74.65M	17.36M	-31.15M	97.82M	25.14M	78.13M	75.90M
Dividends Paid	-	287.00K	974.00K	4.50M	5.10M	18.00M	24.23M	27.25M	36.33M	36.43M	40.72M	33.14M	25.62M	28.84M
FCF to OCF	-72.31%	-68.43%	45.76%	40.77%	34.03%	28.85%	10.42%	42.70%	17.93%	-37.71%	59.39%	19.89%	47.46%	52.99%
Dividend Paid to FCF	-	-1.59%	5.22%	17.07%	15.21%	58.86%	144.08%	36.51%	209.27%	-116.93%	41.62%	131.82%	32.79%	37.99%

Earnings

Report Date	Aug 17, 2017	Oct 26, 2017	Feb 26, 2018	Apr 27, 2018	Aug 24, 2018	Oct 17, 2018	Feb 27, 2019	Apr 24, 2019	Aug 19, 2019	Oct 25, 2019	Feb 24, 2020	Apr 24, 2020	Aug 21, 2020	Oct 23, 2020	Dec 31, 2020	Apr 7, 2021	Aug 23, 2021	Oct 26, 2021	Dec 31, 2021	Apr 22, 2022	Aug 19, 2022	Oct 28, 2022	Dec 31, 2022	Apr 21, 2023	Aug 18, 2023	Oct 24, 2023	Apr 22, 2024	Aug 27, 2024	Oct 25, 2024	Apr 18, 2025	Aug 27, 2025	Oct 23, 2025	Apr 27, 2026	Aug 25, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.31	0.19	0.40	0.40	0.20	0.21	0.17	0.17	0.30	0.23	-	-	-	-	-	-	-	-
EPS Actual	0.21	0.19	0.31	0.08	0.24	0.24	0.31	0.10	0.24	0.27	0.36	-0.12	0.07	0.26	0.53	0.53	0.32	0.34	0.34	-0.18	0.20	0.28	0.23	0.23	0.15	0.05	0.29	0.07	0.11	0.06	0.01	0.02	-0.03	0.11
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3.23%	78.95%	-15.00%	-145.00%	0.00%	33.33%	35.29%	35.29%	-50.00%	-78.26%	-	-	-	-	-	-	-	-
Timing	After-hours	Pre-market	After-hours	Pre-market	Pre-market	After-hours	Pre-market	After-hours	Pre-market	After-hours	Pre-market	After-hours	After-hours	Pre-market	-	Pre-market	After-hours	Pre-market	-	Pre-market	Pre-market	Pre-market	-	After-hours	Pre-market	After-hours	Pre-market	-	-	After-hours	-	-	-	-

Key Statistics & Ratios

Market Cap3.38B

Enterprise Value3.29B

Trailing P/E260.50

Forward P/E0.00

Price / Sales8.62

Price / Book2.42

EPS0.08

Book Value9.01

Revenue (TTM)392.11M

Gross Profit (TTM)264.42M

EBITDA68.78M

Profit Margin3.14%

Operating Margin22.26%

Return on Equity0.65%

Return on Assets0.77%

Shares Outstanding162.27M

Shares Float112.49M

Beta0.28

Dividend Yield0.72%

Dividend Rate0.15

Payout Ratio1.67%

Dividends

20262×

0.05Sep 3, 20260.10May 26, 2026

20251×

0.15May 20, 2025

20241×

0.15May 23, 2024

20231×

0.20May 23, 2023

20221×

0.25May 24, 2022

20211×

0.22Jul 14, 2021

20201×

0.22Jul 14, 2020

20191×

0.17Jul 12, 2019

20181×

0.15May 29, 2018

20171×

0.11Jun 30, 2017

Stock Splits

Sep 16, 20211.8:1
May 29, 20181.5:1